None listed
Conditions
Interventions
Intervention1: SHRUMEI Dark Spot
Corrector serum: 40 l of investigational product(without dilution) was applied on the precut filter paper placedinside the allotted Derma proof Aluminium
Finn cham
Sponsors
Dr. Anil kumar, Director Neeta life sciences Pvt. Ltd,
Eligibility
Inclusion criteria
Inclusion criteria: Voluntary men and women between 18 and 65 years. Photo type III to V. Self-declaration of subject with sensitive skin. Having apparently healthy skin on test area. For whom the investigator considers that the compliance will be correct. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures. Having signed a Consent Form. Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the study. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna ), during the course of the study. Should be able to read and write (in English, Hindi or local language). Having valid proof of identity and age.
Exclusion criteria
Exclusion criteria: Pregnant and nursing mothers Scars, excessive terminal hair or tattoo on the studied area. Henna tattoo anywhere on the body (in case of studies involving hair dyes). Dermatological infection pathology on the level of studied area. Exclusion Criteria Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial. Hypersensitivity, allergy antecedent (to any cosmetic product,raw material or hair dye). Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. Chronic illness which may influence the outcome of the study. Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To determine the irritation and/or sensitization potential of a test material 2.In support of sensitive skin claims and supporting evidence for hypoallergenicity claims after repeated application under occlusive or semi-occlusive patches to the skin of human subjects.Timepoint: Day 1 to Day 40 | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence & rate of adverse eventsTimepoint: Day 1 to Day 40 | — |
Countries
India
Contacts
Public ContactDr Ashok Godavarthi
Radiant Research Services Pvt Ltd.
Outcome results
None listed